rs191822319
Positions:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_006950.3(SYN1):c.1063C>T(p.Leu355=) variant causes a synonymous change. The variant allele was found at a frequency of 0.000112 in 1,199,988 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 35 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00026 ( 0 hom., 8 hem., cov: 23)
Exomes 𝑓: 0.000097 ( 0 hom. 27 hem. )
Consequence
SYN1
NM_006950.3 synonymous
NM_006950.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 3.98
Genes affected
SYN1 (HGNC:11494): (synapsin I) This gene is a member of the synapsin gene family. Synapsins encode neuronal phosphoproteins which associate with the cytoplasmic surface of synaptic vesicles. Family members are characterized by common protein domains, and they are implicated in synaptogenesis and the modulation of neurotransmitter release, suggesting a potential role in several neuropsychiatric diseases. This member of the synapsin family plays a role in regulation of axonogenesis and synaptogenesis. The protein encoded serves as a substrate for several different protein kinases and phosphorylation may function in the regulation of this protein in the nerve terminal. Mutations in this gene may be associated with X-linked disorders with primary neuronal degeneration such as Rett syndrome. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BP6
Variant X-47576226-G-A is Benign according to our data. Variant chrX-47576226-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 465085.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Hemizygotes in GnomAd4 at 8 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SYN1 | NM_006950.3 | c.1063C>T | p.Leu355= | synonymous_variant | 9/13 | ENST00000295987.13 | NP_008881.2 | |
SYN1 | NM_133499.2 | c.1063C>T | p.Leu355= | synonymous_variant | 9/13 | NP_598006.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SYN1 | ENST00000295987.13 | c.1063C>T | p.Leu355= | synonymous_variant | 9/13 | 2 | NM_006950.3 | ENSP00000295987 | P3 | |
SYN1 | ENST00000340666.5 | c.1063C>T | p.Leu355= | synonymous_variant | 9/13 | 1 | ENSP00000343206 | A1 |
Frequencies
GnomAD3 genomes AF: 0.000259 AC: 29AN: 112167Hom.: 0 Cov.: 23 AF XY: 0.000233 AC XY: 8AN XY: 34343
GnomAD3 genomes
AF:
AC:
29
AN:
112167
Hom.:
Cov.:
23
AF XY:
AC XY:
8
AN XY:
34343
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000213 AC: 34AN: 159937Hom.: 0 AF XY: 0.000161 AC XY: 8AN XY: 49759
GnomAD3 exomes
AF:
AC:
34
AN:
159937
Hom.:
AF XY:
AC XY:
8
AN XY:
49759
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000965 AC: 105AN: 1087773Hom.: 0 Cov.: 32 AF XY: 0.0000760 AC XY: 27AN XY: 355249
GnomAD4 exome
AF:
AC:
105
AN:
1087773
Hom.:
Cov.:
32
AF XY:
AC XY:
27
AN XY:
355249
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000258 AC: 29AN: 112215Hom.: 0 Cov.: 23 AF XY: 0.000233 AC XY: 8AN XY: 34401
GnomAD4 genome
AF:
AC:
29
AN:
112215
Hom.:
Cov.:
23
AF XY:
AC XY:
8
AN XY:
34401
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Nov 28, 2017 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 01, 2017 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Epilepsy, X-linked 1, with variable learning disabilities and behavior disorders Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 16, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at